Background: Arteriovenous malformations are potentially serious vascular anomalies that are rarely encountered in the eyelid and require a multidisciplinary approach. Objectives: We would like to describe the technical and clinical aspects related to the treatment of palpebral arteriovenous malformation with selective embolization, followed by surgical resection. Methods: A 40-year-old patient presented with an isolated high-flow palpebral arteriovenous malformation. Transarterial embolization, using a liquid embolic agent (PHIL TM ), was performed in this patient. Results: Angiographic and clinical follow-up revealed good results with clinical regression of the mass. Conclusion: Although endovascular treatment of palpebral arteriovenous malformations is technically challenging, good functional and cosmetic result was achieved. Arteriovenous malformation embolization using PHIL TM seems to be very effective and makes subsequent surgical procedure safe and feasible. Level IV: Evidence obtained from multiple time series with or without the intervention, such as case studies. Dramatic results in uncontrolled trials might also be regarded as this type of evidence.
Introduction
According to the International Society for the Study of Vascular Anomalies, vascular anomalies may be classified based on their haemodynamic category as either high-flow or low-flow lesions. High-flow lesions are divided into arteriovenous malformations (AVMs) and congenital arteriovenous fistulas. Venous malformations, lymphatic malformations and lymphaticovenous malformations are described as low-flow lesions.
1 Palpebral AVMs are rare lesions of not wellestablished origin that pose a difficult diagnostic and therapeutic challenge. They are locally aggressive lesions that may be completely asymptomatic (most cases, according to the National Institutes of Health) or lead to discomfort, pain, pulsation, acute swelling and haemorrhage.
2 Several imaging methods have been suggested to establish the alerted flow pattern through the nidus into the draining venous circulation. The main advantage of magnetic resonance imaging (MRI) is the ability to evaluate the extent of the lesion and estimate the blood flow characteristics within the lesion. Doppler ultrasound imaging allows the evaluation of flow patterns (high and low flow) within AVMs. 3 Vascular anomalies in this location are often supplied from the external carotid circulation and are best visualized by formal catheter angiography.
AVMs are rare, complex lesions that require significant expertise for successful treatment. The aim of interventional management should be complete elimination of the nidus or fistulous connections. Subsequent surgery is usually associated with minor blood loss. Different therapeutic strategies have been proposed in the management of AVMs, including surgery, embolization and stereotactic radiotherapy or combined therapy. 4 Procedures performed in this region are associated with risks connected with unintended central retinal artery (CRA) occlusion. 2 In our case study we would like to present the management strategy for a patient suffering from palpebral AVM who was referred to our clinic for treatment.
Case report
A 40-year-old White man was referred to our clinic because of a swollen, tender right upper eyelid (Figure 1(a) ). His symptoms had begun 2-3 weeks prior to the referral. His medical and ocular histories were unremarkable. Examination of the patient revealed a slightly discoloured, pulsatile mass in the right upper eyelid associated with visual blurring and mild tenderness. Limitations in oculomotricity and proptosis were also seen in this patient. The patient had not noticed similar lesions in other locations, and there was no data suggesting a connection between the lesion and a previous trauma. Gross observation, palpation and slit lamp examination allowed us to exclude an allergic or infectious aetiology. Clinical features of the described lesion, such as bruit and thrill present at auscultation, were suspicious and helped us to establish the right diagnosis.
Doppler ultrasound performed in our patient showed a vascular malformation with a high-flow pattern, typical of the presence of an arteriovenous shunt. MRI examination was performed in our patient to evaluate the extent of involvement of surrounding tissues (Figure 1(b) ), and the AVM measured 3 cm Â 2 cm Â 1.7 cm. Digital subtraction angiography was ordered to depict the detailed angioarchitecture of the vascular anomaly and to confirm the diagnosis of previously described unruptured palpebral AVM.
Angiography of the right common carotid artery was performed from the femoral access. Internal carotid injection revealed the mass of high flow arteries projecting onto the palpebral area and draining to the facial vein (Figure 2(a) ). The diagnostic catheter was replaced with a guiding catheter (Casasco, Balt, France) and a coaxial micro catheter Sonic 1.2F25 (Balt, France) was advanced over the 0.007-inch guide wire (Hybrid 0.007D, Balt, France) to the ophthalmic artery and further beyond the origin of the CRA (Figure 2(b) 
Results
The nidus of the lesion was completely filled with an embolic agent (Figure 3(a) ). Besides the limited subcutaneous oedema no significant complications were seen after the embolization. The palpebral AVM was fully resected on the fifth day after embolization, and no massive blood loss was encountered during surgery ( Figure 3(b) ). Clinical follow-up six months after the procedure revealed a definite improvement. The right upper eyelid remained moderately enlarged but did not impair vision, which was recorded as 20/20. No thrill or bruit was detected, and the range of motion of the eyeball returned to normal.
Discussion
Selective embolization using PHIL TM was performed in our patient as the treatment of choice prior to cosmetic surgery. PHIL TM is a non-adhesive dimethyl sulphoxide-based embolic agent intended for endovascular use. Homogenous fluoroscopic visualization is provided by an iodine component that is covalently bonded to the polymer. PHIL TM is offered in three different formulations (25%, 30%, 35%). In this particular case we decided to use PHIL TM 25%, which is suitable for lower flow scenarios and distal access. The advantages of this embolic agent include moderate inflammatory reaction, lack of associated angionecrosis, faster plug formation and limited computed tomography and MRI artifacts. 5 Due to its white colour PHIL TM provides a good cosmetic outcome without the risk of cutaneous necrosis (potential side effect of absolute alcohol) or black skin colouration (potential side effect of Tantalum in Onyx or SQUID). 6 Selective embolization of superficial orbital vascular malformations carries the risk of intraorbital haematoma or occlusion of the CRA caused by uncontrolled embolic agent injection into the vascular supply of the ophthalmic artery and its collaterals.
2 Unlike in our case, direct puncture and/ or transvenous approach may be considered. If multiple feeders and single draining vein form the structure of the AVM, retrograde embolization or direct delivery of an absolute alcohol or some other liquid embolic agent seem to be more effective. 7 According to the literature PHIL TM has been successfully used in the endovascular management of brain AVMs as well as cranial and spinal arteriovenous fistulas. 5, 8, 9 Our preliminary experience proves that PHIL TM may be an excellent alternative in treating superficial AVMs (including palpebral AVMs) and presents some advantages in comparison with other widely used liquid embolic agents (Onyx, SQUID and n-butyl cyanoacrylate).
Conclusions
In the presented case selective embolization proved to be a safe and useful method and promoted the resection without major blood loss. PHIL TM seems to be a suitable embolic agent for superficial AVM embolization in terms of cosmetic effects. It is also easy to control and is thus a safe embolic material in such clinical scenarios. We would like to emphasize the need for further studies to confirm the safety and effectiveness of PHIL TM used specifically for the treatment of superficial AVMs.
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